MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-18-0003626
Blubell Pharma Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹14.84 Cr
▲ 4% YoY
Net profit · FY 2024
₹82.54 Lakh
Net margin 5.6%
EBITDA · FY 2024
₹1.59 Cr
EBITDA margin 10.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1.75 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Blubell Pharma Private Limited
Data last updated:
Blubell Pharma Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC301713. Its GSTIN is 06AAGCB7793Q1ZS (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sangeet Dixit and Rajan Dhawan.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 211 – A (Ff) Front Side Masjid Moth, Delhi, India – 110049.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.84 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹82.54 Lakh (net margin 5.6%) and EBITDA of ₹1.59 Cr (EBITDA margin 10.7%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 489% over five years.
The company is associated with 1 brand: Blubell pharma group. As per MCA filings, the company has open charges of ₹1.75 Cr on record.
Blubell Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-18-0003626). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website blubellpharma.com.
Company details
CIN U74999DL2016PTC301713
Registration Number 301713
Incorporation Date 20 June 2016
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-18-0003626
Key People
Sangeet Dixit Director Rajan Dhawan Director Recognitions & Rankings of Blubell Pharma
Contact details
Blubell Pharma Private Limited's registered office is in Delhi, Delhi. Its website is blubellpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address211 – A (Ff) Front Side Masjid Moth, Delhi, India – 110049
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Blubell Pharma Private Limited, buy the company report.
Comprehensive company report
Blubell Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Blubell Pharma operates one associated brand: Blubell pharma group. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and distribution services in India. | blubellpharma.com |
Business activity
The main business activity of Blubell Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Blubell Pharma Private Limited, buy the company report.
Financials of Blubell Pharma Private Limited
FY 2025 filings availableBlubell Pharma Private Limited reported revenue of ₹14.84 Cr (up 4% YoY) for FY 2024.
Revenue · FY 2024
₹14.84 Cr ▲ 4%
Net profit · FY 2024
₹82.54 Lakh margin 5.6%
EBITDA · FY 2024
₹1.59 Cr margin 10.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 10%
5 years · compounded
▲ 489%
EBITDA CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 34%
5 years · compounded
▲ 478%
Revenue has grown at a compounded annual rate (CAGR) of 489% over five years, including 4% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.59 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹82.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.7% | ||||
| Net Profit Margin | 5.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Blubell Pharma Private Limited, buy the company report.
Board of directors of Blubell Pharma Private Limited
Blubell Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sangeet Dixit | Director | 20 Jun 2016 | 10 Years 4 Months | Current |
| Rajan Dhawan | Director | 20 Jun 2016 | 10 Years 4 Months | Current |
Auditor
Blubell Pharma Private Limited is audited by S A R S & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S A R S & ASSOCIATES | FY 2021 | 021573N |
Shareholding
The shareholding of Blubell Pharma Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Blubell Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.75 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Mar 2020 | 100336913 | Axis Bank Limited | ₹1.75 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Blubell Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Blubell Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Blubell Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAGCB7793Q1ZS | Haryana | Active | 05 Feb 2019 |
To see the full GST registrations and return filing status of Blubell Pharma Private Limited, buy the company report.
Recent activity
Blubell Pharma Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Rajan Dhawan was appointed as Director on 20 Jun 2016.
AGM
Blubell Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Blubell Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Axis Bank Limited amounted to Rs. 175.00 Lakh with Charge ID 100336913 was registered on 12 Mar 2020.
Appointed
Rajan Dhawan was appointed as Director.
Appointed
Sangeet Dixit was appointed as Director.
Incorporation
20 Jun 2016
Blubell Pharma Private Limited was registered on 20 Jun 2016 with Roc Delhi & aged 10 years 4 months as per MCA records.
Frequently asked questions
Blubell Pharma is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 June 2016 (10+ years old) and is registered under CIN U74999DL2016PTC301713.
Blubell Pharma has 2 current directors:
- Sangeet Dixit - Director
- Rajan Dhawan - Director
The latest financial statements of Blubell Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Blubell Pharma is 06AAGCB7793Q1ZS, registered in Haryana.
The CIN (Corporate Identification Number) of Blubell Pharma is U74999DL2016PTC301713. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Blubell Pharma was incorporated on 20 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Rajan Dhawan was appointed as Director on 20 Jun 2016. Sangeet Dixit was appointed as Director on 20 Jun 2016.
Yes, Blubell Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-HR-18-0003626).
Blubell Pharma can be reached through the website blubellpharma.com. Its registered office is in Delhi, India.
The registered office of Blubell Pharma is at 211 – A Ff Front Side Masjid Moth, Delhi, India – 110049.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages